Mazumder A - Search Results

1

A quantitative reverse transcriptase-polymerase chain reaction assay to identify metastatic carcinoma tissue of origin.

Talantov D, Baden J, Jatkoe T, Hahn K, Yu J, Rajpurohit Y, Jiang Y, Choi C, Ross JS, Atkins D, Wang Y, Mazumder A. Talantov D, et al. Among authors: mazumder a. J Mol Diagn. 2006 Jul;8(3):320-9. doi: 10.2353/jmoldx.2006.050136. J Mol Diagn. 2006. PMID: 16825504 Free PMC article.

2

Prognostic gene expression signatures can be measured in tissues collected in RNAlater preservative.

Chowdary D, Lathrop J, Skelton J, Curtin K, Briggs T, Zhang Y, Yu J, Wang Y, Mazumder A. Chowdary D, et al. Among authors: mazumder a. J Mol Diagn. 2006 Feb;8(1):31-9. doi: 10.2353/jmoldx.2006.050056. J Mol Diagn. 2006. PMID: 16436632 Free PMC article.

3

Development of a clinically feasible molecular assay to predict recurrence of stage II colon cancer.

Jiang Y, Casey G, Lavery IC, Zhang Y, Talantov D, Martin-McGreevy M, Skacel M, Manilich E, Mazumder A, Atkins D, Delaney CP, Wang Y. Jiang Y, et al. Among authors: mazumder a. J Mol Diagn. 2008 Jul;10(4):346-54. doi: 10.2353/jmoldx.2008.080011. Epub 2008 Jun 13. J Mol Diagn. 2008. PMID: 18556775 Free PMC article.

4

Novel genes associated with malignant melanoma but not benign melanocytic lesions.

Talantov D, Mazumder A, Yu JX, Briggs T, Jiang Y, Backus J, Atkins D, Wang Y. Talantov D, et al. Among authors: mazumder a. Clin Cancer Res. 2005 Oct 15;11(20):7234-42. doi: 10.1158/1078-0432.CCR-05-0683. Clin Cancer Res. 2005. PMID: 16243793

5

Gene-expression signatures in oncology diagnostics.

Mazumder A, Wang Y. Mazumder A, et al. Pharmacogenomics. 2006 Dec;7(8):1167-73. doi: 10.2217/14622416.7.8.1167. Pharmacogenomics. 2006. PMID: 17184204 Review.

6

Development of a multiplexed urine assay for prostate cancer diagnosis.

Vener T, Derecho C, Baden J, Wang H, Rajpurohit Y, Skelton J, Mehrotra J, Varde S, Chowdary D, Stallings W, Leibovich B, Robin H, Pelzer A, Schäfer G, Auprich M, Mannweiler S, Amersdorfer P, Mazumder A. Vener T, et al. Among authors: mazumder a. Clin Chem. 2008 May;54(5):874-82. doi: 10.1373/clinchem.2007.094912. Epub 2008 Mar 13. Clin Chem. 2008. PMID: 18339699 Clinical Trial.

7

Validation and integration of gene-expression signatures in cancer.

Mazumder A, Palma AJ, Wang Y. Mazumder A, et al. Expert Rev Mol Diagn. 2008 Mar;8(2):125-8. doi: 10.1586/14737159.8.2.125. Expert Rev Mol Diagn. 2008. PMID: 18366298 Review. No abstract available.

8

Molecular and cellular approaches to patient management in oncology.

Mazumder A, Wang Y, Godsey JH. Mazumder A, et al. Per Med. 2006 Aug;3(3):299-310. doi: 10.2217/17410541.3.3.299. Per Med. 2006. PMID: 29788655

9

Quantitative, spatial resolution of the epigenetic field effect in prostate cancer.

Mehrotra J, Varde S, Wang H, Chiu H, Vargo J, Gray K, Nagle RB, Neri JR, Mazumder A. Mehrotra J, et al. Among authors: mazumder a. Prostate. 2008 Feb 1;68(2):152-60. doi: 10.1002/pros.20675. Prostate. 2008. PMID: 18058812

10

Technology for microarray analysis of gene expression.

Watson A, Mazumder A, Stewart M, Balasubramanian S. Watson A, et al. Among authors: mazumder a. Curr Opin Biotechnol. 1998 Dec;9(6):609-14. doi: 10.1016/s0958-1669(98)80138-9. Curr Opin Biotechnol. 1998. PMID: 9889134 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

605 results

Search Page

Filters